CHR d'Orléans
Orléans, 45000, France
NCT Number: NCT03357198
Cough Peak Flow (CPF) seems to be an efficient tool to assess cough capacity for the intensive care unit (ICU) ventilated patient. CPF can be used in the ventilator weaning process, as reflecting the upper airways protection capacity.
CPF requires disconnection of the patient from the ICU ventilator, supplemental material (handheld spirometer, antibacterial filter) and an excellent synchronization between the specialized caregiver and the patient.
We aimed that CPF with the ventilator built-in flow-meter is correlated with CPF using a handheld flowmeter connected to the endotracheal tube.
Looking for future studies?
Notify Me18 year and older
All sexes
Observational
Orléans, 45000, France
Healthy volunteers accepted: No
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Exclusion criteria
Time frame: Within 1 hour before mechanical ventilation termination (extubation)
Correlation coefficient for the two CPF assessment methods, on extubation day
Time frame: During the mechanical ventilation until 72 hours post extubation
Thresholds of CPF will be tested as predictors of weaning success
Time frame: During the mechanical ventilation until 72 hours post extubation
Assess the correlation between CPF and length of mechanical ventilation
Time frame: During the mechanical ventilation until 72 hours post extubation
Centre Hospitalier Régional d'Orléans
Other
Correlation of Cough Peak Flow Measurement by an Electronic Handheld Spirometer Connected to the Endotracheal Tube and by the Intensive Care Unit Ventilator Flowmeter.
Acronym: COUGH-ICU
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT05674812
Pathologic Processes, Pathological Conditions, Signs and Symptoms
Tianjin, Tianjin Municipality, China
View Trial DetailsNCT04204967
Analgesics, Opioid, Respiration Disorders
Roma, Italy
View Trial DetailsNCT07571317
Critical Illness, Disease Attributes
Istanbul, Turkey (Türkiye)
View Trial DetailsNCT06304493
Behavior, Health Behavior
Aurora, Colorado, United States
View Trial Details